Maeda, H.; Oba, K.; Kashiwabara, K.; Aoyama, T.; Mayanagi, S.; Kanda, M.; Honda, M.; Muto, M.; Sakamoto, J.; Yamagishi, H.;
et al. Efficacy of Adjuvant Chemotherapy for T1-2 Stage III Colorectal Cancer. Cancers 2025, 17, 3856.
https://doi.org/10.3390/cancers17233856
AMA Style
Maeda H, Oba K, Kashiwabara K, Aoyama T, Mayanagi S, Kanda M, Honda M, Muto M, Sakamoto J, Yamagishi H,
et al. Efficacy of Adjuvant Chemotherapy for T1-2 Stage III Colorectal Cancer. Cancers. 2025; 17(23):3856.
https://doi.org/10.3390/cancers17233856
Chicago/Turabian Style
Maeda, Hiromichi, Koji Oba, Kosuke Kashiwabara, Toru Aoyama, Shuhei Mayanagi, Mitsuro Kanda, Michitaka Honda, Masaru Muto, Junichi Sakamoto, Hisakazu Yamagishi,
and et al. 2025. "Efficacy of Adjuvant Chemotherapy for T1-2 Stage III Colorectal Cancer" Cancers 17, no. 23: 3856.
https://doi.org/10.3390/cancers17233856
APA Style
Maeda, H., Oba, K., Kashiwabara, K., Aoyama, T., Mayanagi, S., Kanda, M., Honda, M., Muto, M., Sakamoto, J., Yamagishi, H., & Yoshikawa, T.
(2025). Efficacy of Adjuvant Chemotherapy for T1-2 Stage III Colorectal Cancer. Cancers, 17(23), 3856.
https://doi.org/10.3390/cancers17233856
